中商官网
研究报告
达瑞生物（832705）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 64707300.0000 | 11085100.0000 | 13570100.0000 | 12073400.0000 | 85460800.0000 | 50208900.0000 | 35251900.0000 |
| 2014 | 96196700.0000 | 8855400.0000 | 13297500.0000 | 12014600.0000 | 128000000.0000 | 80721800.0000 | 47366500.0000 |
| 2015 | 201000000.0000 | 24772100.0000 | 33833200.0000 | 29391000.0000 | 509000000.0000 | 71632800.0000 | 438000000.0000 |
| 2016 | 415000000.0000 | 41368200.0000 | 60981600.0000 | 52762200.0000 | 625000000.0000 | 135000000.0000 | 491000000.0000 |
| 2017 | 324000000.0000 | 13715400.0000 | 14474500.0000 | 12864600.0000 | 718000000.0000 | 206000000.0000 | 512000000.0000 |
| 2018 | 290000000.0000 | -36292300.0000 | -36424200.0000 | -31017000.0000 | 679000000.0000 | 201000000.0000 | 478000000.0000 |
| 2019 | 282000000.0000 | -25013600.0000 | -24898200.0000 | -22130600.0000 | 638000000.0000 | 183000000.0000 | 454000000.0000 |
| 2020 | 337000000.0000 | 75303600.0000 | 74929700.0000 | 58719200.0000 | 756000000.0000 | 245000000.0000 | 511000000.0000 |
| 2021 | 372000000.0000 | -26310500.0000 | -26329200.0000 | -16995200.0000 | 843000000.0000 | 138000000.0000 | 705000000.0000 |
| 2022 | 454000000.0000 | 18925900.0000 | 18732700.0000 | 20269400.0000 | 889000000.0000 | 183000000.0000 | 706000000.0000 |
| 2023 | 200000000.0000 | -62183200.0000 | -65505200.0000 | -84737800.0000 | 726000000.0000 | 115000000.0000 | 611000000.0000 |
| 2024 | 204000000.0000 | -20473900.0000 | -20916800.0000 | -21232500.0000 | 717000000.0000 | 127000000.0000 | 590000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 17.13 | 20.97 | 15.88 | 41.3300 | 3.7600 | 1.69 | 0.76 |
| 2014 | 9.21 | 13.82 | 10.39 | 29.1800 | 5.6700 | 1.89 | 0.75 |
| 2015 | 10.95 | 16.83 | 6.65 | 16.3700 | 6.8100 | 2.00 | 0.39 |
| 2016 | 7.23 | 14.69 | 9.76 | 11.5100 | 9.1300 | 2.16 | 0.66 |
| 2017 | 0.93 | 4.47 | 2.02 | 3.6800 | 4.3400 | 1.27 | 0.45 |
| 2018 | -18.62 | -12.56 | -5.36 | -4.8000 | 3.3500 | -- | 0.43 |
| 2019 | -15.25 | -8.83 | -3.90 | -3.4500 | 3.4600 | 1.51 | 0.44 |
| 2020 | -6.53 | 22.23 | 9.91 | 12.6200 | 3.3900 | 2.11 | 0.45 |
| 2021 | 2.96 | -7.08 | -3.12 | -2.6600 | 3.7300 | 3.13 | 0.44 |
| 2022 | 4.41 | 4.13 | 2.11 | 2.9400 | 5.5000 | 2.86 | 0.51 |
| 2023 | -31.00 | -32.75 | -9.02 | -12.9200 | 2.5500 | 1.22 | 0.28 |
| 2024 | -8.82 | -10.25 | -2.92 | -3.5200 | 3.2200 | 1.70 | 0.28 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 58.75 | 41.25 | 1.4100 | 1.0300 |
| 2014 | 63.06 | 37.01 | 1.3400 | 1.1200 |
| 2015 | 14.07 | 86.05 | 6.8400 | 5.5300 |
| 2016 | 21.60 | 78.56 | 3.7200 | 3.2200 |
| 2017 | 28.69 | 71.31 | 2.3100 | 1.8200 |
| 2018 | 29.60 | 70.40 | 2.0300 | 1.6000 |
| 2019 | 28.68 | 71.16 | 1.8800 | 1.4300 |
| 2020 | 32.41 | 67.59 | 1.7100 | 1.3500 |
| 2021 | 16.37 | 83.63 | 3.8000 | 3.3900 |
| 2022 | 20.58 | 79.42 | 3.2000 | 2.8200 |
| 2023 | 15.84 | 84.16 | 3.4200 | 2.9900 |
| 2024 | 17.71 | 82.29 | 3.7200 | 3.0000 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 53622100.0000 | 9224100.0000 | 10849800.0000 | -11800.0000 |
| 2014 | 87341300.0000 | 12073000.0000 | 13267600.0000 | -62000.0000 |
| 2015 | 179000000.0000 | 19672100.0000 | 36566700.0000 | -2785100.0000 |
| 2016 | 385000000.0000 | 41792100.0000 | 47072300.0000 | -1877400.0000 |
| 2017 | 321000000.0000 | 29680500.0000 | 29288200.0000 | 2888500.0000 |
| 2018 | 344000000.0000 | 37843100.0000 | 35521600.0000 | 5436100.0000 |
| 2019 | 325000000.0000 | 43525900.0000 | 32327600.0000 | 3521000.0000 |
| 2020 | 359000000.0000 | 47291800.0000 | 41257500.0000 | 3289000.0000 |
| 2021 | 361000000.0000 | 50929900.0000 | 39321900.0000 | 1268500.0000 |
| 2022 | 434000000.0000 | 57059300.0000 | 37442100.0000 | 414200.0000 |
| 2023 | 262000000.0000 | 43762700.0000 | 31776900.0000 | 368600.0000 |
| 2024 | 222000000.0000 | 41874700.0000 | 24740800.0000 | 401600.0000 |